Yinghao Lu
Overview
Explore the profile of Yinghao Lu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
107
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lyu F, Gong H, Wu X, Liu X, Lu Y, Wei X, et al.
Leukemia
. 2024 Nov;
39(2):473-481.
PMID: 39580582
Chronic graft-versus-host disease (cGVHD), characterized by chronic tissue inflammation and fibrosis involving multiple organs, remains a major complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Dimethyl fumarate (DMF) is an...
2.
BRG1 promotes progression of B-cell acute lymphoblastic leukemia by disrupting PPP2R1A transcription
Kang Q, Ma D, Zhao P, Chai X, Huang Y, Gao R, et al.
Cell Death Dis
. 2024 Aug;
15(8):621.
PMID: 39187513
Despite advancements in chemotherapy and the availability of novel therapies, the outcome of adult patients with B-cell acute lymphoblastic leukemia (B-ALL) remains unsatisfactory. Therefore, it is necessary to understand the...
3.
Liang J, Liao L, Xie L, Tang W, Yu X, Lu Y, et al.
J Transl Med
. 2024 Jan;
22(1):117.
PMID: 38291470
Background: Radioresistance is a primary factor contributing to the failure of rectal cancer treatment. Immune suppression plays a significant role in the development of radioresistance. We have investigated the potential...
4.
Lu Y, Liao L, Du K, Mo J, Zou X, Liang J, et al.
BMC Cancer
. 2024 Jan;
24(1):133.
PMID: 38273249
Purpose: There are limited and no standard therapies for recurrent glioblastoma. We herein report the antitumour activity and safety of sintilimab, bevacizumab and temozolomide (TMZ) in recurrent glioblastoma. Methods: We...
5.
Liu K, Xu H, Gao X, Lu Y, Wang L, Ren Z, et al.
Int J Mol Sci
. 2024 Jan;
25(1).
PMID: 38203357
Cucumbers are frequently affected by gray mold pathogen , a pathogen that causes inhibited growth and reduced yield. Jasmonic acid (JA) plays a primary role in plant responses to biotic...
6.
Li J, Li B, Xu J, Wang H, Gao Q, Ye F, et al.
Oncol Lett
. 2023 Feb;
25(3):132.
PMID: 36844617
Non-intestinal adenocarcinoma of nasal cavity and paranasal sinuses (n-ITAC) is a heterogeneous tumor, which has rarely been reported in previous studies. Most high-grade n-ITAC has poor prognosis and there is...
7.
Liu L, Wang S, Jiang E, Zhang Y, Li J, Fu Y, et al.
Blood Cancer J
. 2022 Jun;
12(6):92.
PMID: 35750668
No abstract available.
8.
Liang Y, Gong H, Li Y, Lu Y, Wu X, Zhang X, et al.
J Biomed Nanotechnol
. 2021 Oct;
17(10):2053-2061.
PMID: 34706805
Recently, immunomodulation based on biomaterials has held great promise for preventing and treating cancer. Tumor vaccination can be considered as one of promising immunotherapies, compared with the vaccines for infectious...
9.
Yang J, Liu P, Ma D, Zhao P, Zhang Y, Lu Y, et al.
Pediatr Hematol Oncol
. 2020 Nov;
38(1):36-48.
PMID: 33231128
Development of chemo‑resistance is ultimately responsible for treatment failure and relapse in B-cell acute lymphoblastic leukemia (B-ALL). However, the mechanism underlying glucocorticoid (GC) resistance remains unclear. This study was performed...
10.
Zeng Y, Wang S, Wang J, Liu L, Su Y, Lu Z, et al.
Sci Rep
. 2018 Feb;
8(1):2479.
PMID: 29410500
HLA-haploidentical hematopoietic stem cell transplantation (HSCT) may be an option for severe aplastic anemia (SAA) patients. However, to date, no large-sample studies have been performed to determine which types of...